Choice Equity Broking is bullish on Apollo Pipes has recommended buy rating on the stock with a target price of Rs 420 in its research report dated October 31, 2025.
Earlier, Apollo Pipes had hit a 52-week high of Rs 798 apiece on February 9, 2024.
Shilpa Medicare shares closed 8.49 percent up at Rs 489 on the National Stock Exchange.
Bajaj Finance sold 0.88 percent stake in Strides Pharma Science and Amansa Holding bought 1.24 percent stake.
YES Securities is bullish on Apollo Pipes has recommended buy rating on the stock with a target price of Rs 820 in its research report dated October 27, 2023.
The elevated Put-call ratio and the rise in India's VIX suggest a cautious sentiment and the possibility of profit-booking at higher levels.
YES Securities is bullish on Apollo Pipes has recommended buy rating on the stock with a target price of Rs 757 in its research report dated May 09, 2023.
The 17,600 level is expected to be crucial for further direction of the Nifty50 going forward and, if the index manages to hold the 17,500-17,600 area, then 18,000 can be a possibility in coming sessions, experts said
YES Securities is bullish on Apollo Pipes has recommended buy rating on the stock with a target price of Rs 600 in its research report dated January 27, 2023.
Net Sales are expected to increase by 4 percent Y-o-Y (down 1.1 percent Q-o-Q) to Rs. 216.5 crore, according to Yes Securities.